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It has been demonstrated in previous studies that
there are several morphological variants of membrano-
proliferative glomerulonephritis (MPGN) [1—3]. In
most cases mesangial cell proliferation and an increase
in mesangial matrix are associated with capillary wall
thickening ("classical MPGN"). In some cases, in
addition to the previous findings, there is an accentua-
tion of lobulation of glomerular tufts due to the pres-
ence of sclerotic nodules in most of the centrilobular
areas. This is accompanied by peripheral displacement
or obliteration of capillary lumens (lobular GN or
"MPGN with lobular pattern"). More or less abun-
dant epithelial crescents may be seen in both variants.
However, analysis of the capillary wall thickening
by light and electron microscopy reveals two types of
involvement: In the first, thickening of the capillary
walls is due to an interposition of mesangial matrix
between the endothelium and a normal basement
membrane, producing a "double contour" appearance.
Electron microscopy, as well as immunofluorescence
microscopy, reveals in all cases the presence of ab-
normal subendothelial deposits. This variety is called
MPGN with subendothelial deposits (SED). In the
second, the thickening of the capillary walls is due to
the presence of an abnormal dense refractile material
located in the basement membrane itself. "Double
contours" here are an inconstant finding. This variety
warrants the name of MPGN with dense intramem-
branous deposits (DIMD); it has recently been called
laminal glomerulonephritis [4].
These two varieties of MPGN are at present not dis-
tinguished one from another in most clinical studies
because it may be difficult to recognize MPGN with
DIMD on light microscopy. Therefore, with one ex-
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ception [5], there are no extensive studies dealing with
this specific entity.
We observed 44 cases of this variety of MPGN and
report here detailed clinical and complement studies,
together with histological data in these cases for
comparison with 84 cases of MPGN with SED seen
during the same period of time.
Methods
Out of the 128 renal biopsy specimens studied in our
laboratory between 1959 and 1974 and for which the
diagnosis of MPGN was established, we found in
44 cases by light or electron microscopy or both the
morphologic characteristics of "dense deposit dis-
ease". The biopsy specimens were obtained at various
stages of the disease (12 days to eight years) (Fig. 1),
less than one year after the apparent onset in 26
patients. Repeat biopsies were performed in nine
patients and biopsy specimens of the graft kidney were
obtained in five.
For light microscopic studies, renal biopsy specimens
were fixed for 6 to 24 hr in Dubosq-Brasil fluid and,
subsequently, for 24 hr in 1 5% formalin. All the speci-
mens were then embedded in paraffin and cut at 2 to 3 i.
Four stains were used: hematoxylin-eosin, trichrome
light green, periodic acid-Schiff with hematoxylin, and
silver impregnation according to Wilder.
Electron microscopic studies were performed in
14 patients. Following fixation in osmium tetroxide
and postfixation in glutaraldehyde, the specimens were
embedded in epoxy resin (Epon) and stained with
uranyl acetate and lead citrate. In 12 cases, silver stain-
ing methods were used to demonstrate clearly the exact
location of the deposits [6].
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in the plasma of 17 patients by the radial diffusion
method. The mean normal concentration (±2 SD) was
98%±29.
I i4
Immunofluorescence microscopic studies were done
in 12 cases. The following sera labeled with fluorescein
isothiocyanate were used in all cases: anti-IgG, anti-
IgA, anti-IgM, anti-fl1C, antialbumin and antifibrino-
gen (Hyland Laboratories). Anti-Cl q serum was used
in five cases, anti-C4 in five, and antiproperdin in four.
The C3 component of complement was measured in
the plasma of 23 patients, the C4 component of com-
plement in 20 and the C3 PA (GBG)in 17 by the radial
diffusion method using commercially available im-
munoplates (Hyland: C3, Behringwerke Laboratories:
C4 and C3 PA).
The mean normal concentrations (±2 SD) deter-
mined from results of normal children were 122
50 mg/100 ml for C3, 44± 21 mg/l00 ml for C4 and
25±12 mg/100 ml for C3 PA.
The CI q component of complement was measured
Clinical observations
The disease affected both sexes equally (24 girls and
20 boys). Symptoms never occurred before the age of
4 yr and most patients were more than 8 yr old at the
onset (Fig. 2).
The appearance of urinary symptoms was preceded
by an acute infection in 23 patients (Fig. 3): sore
throat in 20 cases with an increase in ASO titer
(>400 units) in 9 of these, meningococcal meningitis
in 1 case and unexplained fever in 2 cases. A partial
lipodystrophy was associated with the nephropathy in
three patients. Determinations for systemic lupus ery-
thematosus were negative in all the patients who were
tested.
The presenting symptoms were edema in 17 children
and macroscopic hematuria in 16. In the remaining
11 patients, proteinuria was discovered by routine
urinalysis (Fig. 4). All patients had proteinuria, which
was accompanied by a nephrotic syndrome in 37. The
nephrotic syndrome was persistent during the entire
course of the disease in 24 patients and transient in
13 others. Seven children never had a nephrotic syn-
drome (Fig. 4). In all patients but one, proteinuria was
associated with hematuria which was macroscopic in
23 of them, mainly during the course of the first year
yr of the disease. Two patients, both with lipodystrophy,
had recurrent episodes of macroscopic hematuria after
the first year of the disease.
Eleven patients had hypertension at onset which was
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Fig. 2. Age at onset.
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Fig. 1. Interval between onset and first renal biopsy.
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transient in all but two (Fig. 4). Seventeen patients
presented with renal insufficiency at onset, and in four
others, azotemia appeared within a few weeks. Of the
21 patients in which the glomerular filtration rate
(GFR) was decreased, 10 had a rapidly progressive
course and developed terminal renal failure within 3
to 20 months. (Renal biopsy revealed diffuse epithe-
hal crescents in all.) In five patients the evolution to-
wards a terminal stage was slower (two years, six
months to ten years, three months). The six remaining
patients recovered from their early episode of renal in-
sufficiency.
Renal insufficiency appeared several months later in
three patients and progressed to terminal renal failure
within six to seven years.
Subendothelial
deposits
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Fig.'3. Etiology.
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Five patients were transplanted, with removal of the
homolateral kidney. Removal of the second kidney
was performed in one patient. Recurrence of the lesion
was seen in the five patients whose transplant was
biopsied. Three of them developed renal failure which
was considered to be due to a severe chronic rejection.
Immunosuppressive therapy (chlorambucil) was ad-
ministered to 30 patients for a variable period of time
_______ (21) and at various stages of the disease with no demon-
strable effect.
In three children a disappearance of all symptoms
was observed. In two, the remission lasted, respectively,
two and three years but was followed by a relapse. One
of them died 9 years, two months after onset; the other
one is in chronic renal failure after a follow-up of
12 years. The third patient has been in remission for
39% three years, nine months after a course of two years
(17) characterized by proteinuria and recurrent macro-
scopic hematuria.
At the latest evaluation, the status of the 44 patients
was as follows (Fig. 5): 18 patients were dead or re-
16% ceiving repetitive hemodialysis; 1 was in chronic renal(7) failure; 24 had persistent proteinuria, associated with(l3) a nephrotic syndrome in 11; and 1 has been in corn-
plete remission for three years, nine months. For the(24)
survivors the period of follow-up was variable: four
52% months to ten years, ten months with a mean of four
46% years, nine months.
The actuarial survival curve (Fig. 6) shows that the
50% statistical mortality occurred in this group of
patients in the ninth year.
______
Morphological study
Light microscopy (Figs. 7 and 8). In all patients
lesions affected the majority of glomeruli. The changes
consisted of hypertrophy and hypercellularity of the
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Fig. 4. Clinical symptoms of membranoproliferative glomerulo-
nephritis (MPG N).
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Fig. 5. Status at last follow-up observation.
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Fig. 6. Actuarial survival curve. The 50% statistical mortality
occurs between the ninth and tenth years.
tuft, increase in mesangial matrix and thickening of the
capillary walls.
The proliferation involved mainly the mesangial
cells, and was mild in 11 patients, moderate in 22 and
marked in 11. An abnormal number of neutrophils was
found in the lumens of some glomerular capillaries in
19 patients. The increase in mesangial matrix was of
variable intensity, but in seven patients it was so
marked that it formed centrilobular sclerotic nodules
which gave a lobulated appearance to the tuft (Fig. 8).
In the mesangium of 22 patients, refractile granules of
varying size—often colored red by trichrome stains—
were present. In one patient there were also curved
violaceous deposits in the mesangium. In 13 patients
(of whom 2 had a lobular pattern), more or less diffuse
epithelial crescents were present in Bowman's space.
In all cases thickening of the glomerular capillary
walls was due to the presence of more or less diffuse,
dense deposits replacing the basement membrane,
which took on a ribbon-like, refractile appearance
(Figs. 7 and 8). On silver impregnation the basement
membrane itself was thickened by a dense material
colored brown. In half of the cases, the presence of
segmental "double contours" indicated that peripheral
extensions of mesangial matrix were also present. These
same "dense deposits" were found focally in Bow-
man's capsule and tubular basement membranes. It
was not rare to find them equally in arteriole walls, in
a subendothelial position. In 15 patients, bulky sub-
epithelial deposits ("humps") were seen on the epi-
thelial side of the basement membrane. In two patients,
some capillary loops had a hatched appearance similar
to that seen in extramembranous glomerulonephritis
(subepithelial deposits separated by "spikes").
In the serial biopsy specimens, there were some modi-
fications of the initial pattern. In one case the dense
deposits had partly regressed, but in the eight other
-o
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Fig. 7. MPGN with dense intramembranous deposits: In this case
mesangial hypercellularity was mild but all the basement mem-
branes were thickened and refractile (trichrome, x 475).
Fig. 8. MPGN with dense intramembranous deposits: Note the
lobular pattern and the ribbon-like appearance of the glomerular
basement membranes at the periphery of the lobules as well as in
segments of Bowman's capsule (trichrome, x 340).
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Fig. 9. MPGN with dense intramembranous deposits: Bands of electron-dense deposits are seen in the midportion of the lamina densa
(7/) between the two light layers (7) (uranyl lead; electron micrograph, x 18,000). Subendothelial mesangial expansions giving a
"double contour" appearance reduce the capillary lumen. Note foot-processes fusion.
C-
 
I—
I 
' 
: 
I 
'C
 
.
.
 
p 
-
 
t 
'P
r' ;t
 
!%
Al
 
Dense deposit disease 209
Fig. 10. MFGN with dense intramembranous deposits: Discontinuous and segmental intramembranous dense "deposits" are present
(silver methenamine; electron micrograph, x 4,500). The thickening of the basement membrane is predominantly seen next to the
mesangial stalk (,'). The abnormal material protrudes towards the internal side of the basement membrane. Note the presence of
"humps" (77) and of mesangial deposits (7 / 7).
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specimens the deposits in the basement membranes
had clearly increased, and were calcified in the tissue
obtained by nephrectomy in two hemodialyzed child-
ren. Mesangial proliferation was milder in four
patients. An interesting feature was the complete dis-
appearance of the lobular pattern in one patient.
In the specimens of the biopsies performed in the
transplanted kidneys, "dense deposits" were found in
the glomerular, capsular and tubular basement mem-
branes in all patients although they were very seg-
mental. Mesangial proliferation was always absent.
Electron microscopy. In all glomeruli examined, the
constant lesion was the presence of a strongly electron-
dense material located in the midportion of the base-
ment membrane, taking the place of and widening the
normal lamina densa. When stained by uranyl lead,
this abnormal substance appeared homogeneous and
much denser than normal lamina densa. It was always
well delineated from the mildly electron-dense lamina
rara interna and externa. When impregnated by silver
methenamine, this material exhibited the same strong
affinity for silver as the lamina densa.
The abundance and the diffusion of these dense
"deposits" were variable. In 11 patients, the thicken-
ing affected the majority of the capillary loops but two
different pictures were observed: in six cases, there was
a continuous linear distribution of the abnormal
material producing a thick dense but regular basement
membrane (Fig. 9); in five cases, there was an irregular
fusiform swelling of the lamina densa. In these last five
cases, silver impregnation best demonstrated the reg-
ular external edge of lamina densa and the irregular
protrusion of the dense material towards the endothe-
hal cells. The width of the pathological basement mem-
brane usually varied between 5000 and 15,000 A but it
could reach 40,000 A. In three cases the deposits were
very segmental located predominantly in the basement
membrane adjacent to the mesangial areas (Fig. 10).
in three cases a few granular, moderately dense de-
posits were observed on the internal side of the dense
basement membrane.
In ten patients, finely granular, moderately dense
subepithelial deposits were clearly visible (Fig. 11).
They were hump-like and numerous in six cases (Figs.
10 and 11), but rare and predominantly located on the
basement membrane adjacent to the mesangial stalks
in four. In two of these ten patients, the hump-like de-
posits were associated in some loops with flat subepi-
thelial deposits which were often separated by very
thick and dense spikes. Moreover, in some loops,
patchy deposits of weaker density were embedded in
the abnormally dense lamina densa mimicking the
lesions observed in advanced stages of membranous
nephropathy.
Mesangial proliferation was sometimes very marked
and accompanied by considerable increase in the mes-
angial matrix and circumferential interposition of
mesangial cells and matrix, giving a "double contour"
appearance to the capillary walls. Most often mesan-
gial proliferation was moderate or minimal.
Diffuse mesangial deposits in every stalk were pre-
sent in all cases. They were exclusively situated along
the basement membrane only once. In all the other
cases they were predominantly located in the mesangial
matrix where they formed round nodules or masses
bulging into the basement membrane-like material.
They appeared either very dense and homogeneous or
moderately dense and finely granular.
In five patients, there were numerous neutrophils
present in the glomerular capillary lumens.
The visceral epithelial cells showed proliferation in
two cases resulting in crescents formations. They were
always hypertrophied and contained in their cytoplasm
vacuoles with a single limiting membrane. These
vacuoles were either empty or filled with more or less
electron-dense material. A diffuse fusion of their foot
process was rare; most often it was segmental and was
always observed in association with subepithelial de-
posits.
Furthermore, segmental dense deposits of the ab-
normal substance were seen in all cases on the external
side of Bowman's capsule and basement membranes of
proximal convoluted tubules. They were also present
in the wall of an intertubular capillary in one patient
and in the internal elastic lamina of an arteriole in an-
other.
Immunofluorescence microscopy. In the 12 cases
studied, bright deposits of C3 were always found in the
mesangium although different patterns could be ob-
served. In the usual pattern there were small scattered
granules in variable numbers (Fig. 12), but rarely there
were clusters of nodules or voluminous masses outlin-
ing the mesangial stalk. Deposits of C3 were also found
on the glomerular basement membrane, but were weak
and of a continuous or discontinuous "linear" pat-
tern (Fig. 12). In four instances, however, basement
membrane appeared granular and intensely fluorescent.
Deposits of C3 were also observed on segments of
variable thickness along Bowman's capsule and tubu-
lar basement membranes.
In contrast to these diffuse deposits of C3, there were
in most instances no deposits of immunoglobulins
Clq, C4 or properdin.
Results of plasma C3, Clq, C4 and C3 PA measurements
Measurements of plasma C3 concentrations were per-
formed in 23 patients (Fig. 13). In five cases, only one
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Fig. 11. MPGN with dense intramembranous deposits: A hump-like deposit is superimposed on a band-like electron-dense deposit which
occupies the midportion of the thickened basement membrane (uranyl lead; electron micrograph, x 15,000). Note the difference of
density and granularity of the two kinds of material: very dense and homogeneous in the basement membrane (/), moderately dense
and finely granular in the subepithelial deposit ( /).
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estimation was done and concentrations were low.
Eighteen patients had serial estimations and except for
one, all had persistently low concentrations (<50 mg/
100 ml); the last patient had normal concentrations at
onset and low C3 concentrations after the second year.
In four of these patients, C3 concentrations were
studied after transplantation (Pr Crosnier): concentra-
tions were low in two, normal in one and normal for
several months before falling to 60 mg/100 ml in the
other.
Measurements of plasma Clq concentrations were
performed in 17 patients (Fig. 14). In six only one
estimation was done: the concentrations were normal
in five and low in one. Serial estimations were per-
formed in the other 11 patients. Fluctuations occurred
in four while seven had normal concentrations.
Measurements of plasma C4 concentrations were
performed in 20 patients (Fig. 14). In the seven in
whom only one estimation was done, the concentra-
tions were normal in all. Serial estimations were done
in the other 13 patients. Fluctuations occurred in three
while ten always had normal concentrations.
Measurements of plasma C3 PA concentrations were
Cs
MPGN with dense deposits
%
150
IOU
Fig. 12. MPGN with dense intramembranous deposits: Anti-fl1C
globulin (fluorescent microscopy, x 300). Note weak linear fixa-
tion along the capillary basement membranes and the bright
granular deposits in the mesangium.
mg/00 ,s/ • mg/JO0 ml mg/IOU ml
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Cq CpaDuration of illness, yr
Fig. 13. Plasma C3 concentrations in MPG N with dense intra-
membranous deposits at various periods of the disease (23 patients).
Fig. 14. Plasma Clq, C4, C3 and C3 PA concentrations in MPGN
with dense intramembranous deposits.
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performed in 17 patients (Fig. 14). In the four patients
in whom only one estimation was done, the concentra-
tions were normal in two and low in two. Serial estima-
tions were performed in the other 13 patients. Fluctua-
tions occurred in nine while four had normal con-
centrations.
Discussion
MPGN with dense intramembranous deposits
(DIMD) was described as a separate entity by Berger
and Galle in 1963 {7}, and on several occasions we
noted its frequency in children [1, 8, 9]. However, little
attention was paid to this condition except in the
French literature [10—13]. It was rediscovered by
Mathew and Kincaid-Smith in 1971 [14], and since that
time several reports have mentioned this anomaly of
the basement membrane in some cases of MPGN [15—
20].
Although it may closely resemble MPGN with sub-
endothelial deposits (SED) because of the mesangial
hypercellularity and the increase in mesangial matrix,
MPGN with DIMD can be easily distinguished from
it. By light microscopy, using oil immersion and the
appropriate stains (trichrome and silver), the basement
membrane proper is thickened, refractile and takes on
a ribbon-like appearance. By electron microscopy the
basement membrane is swollen by an abnormal,
strongly electron-dense material located between the
epithelial and the endothelial layers, and replacing the
lamina densa.
From a clinical point of view, a recent study [5] has
shown that clinical presentation and clinical course as
well as outcome are similar to those of MPGN with
subendothelial deposits. We compared the 44 patients
in this study with 88 patients with MPGN and SED
who were observed during the same period of time and
could not find significant clinical differences between
the two groups (Figs. 2 through 5). MPGN with
DIMD is rarely discovered by a routine urinalysis
(25% vs. 45%), and it often follows a streptococcal in-
fection (20% vs. 11%). Only in this group have we
found patients affected with partial lipodystrophy [21—
24]. It is usually accompanied by a persistent nephro-
tic syndrome (55% vs. 42%) and by a macroscopic
hematuria (52% vs. 37%). It has apparently a poorer
prognosis, since at the end of follow-up, 41% of the
patients with DIMD have died of renal insufficiency or
are receiving repetitive hemodialysis, while only 25%
of the patients with SED have reached the stage of
terminal renal failure. This fact is well illustrated by
the actuarial survival curves and is mainly due to a
greater frequency of association with epithelial cres-
cents (Fig. 6).
Plasma complement [25—27] and immunofluores-
cence microscopic studies [12, 13, 25, 27] seem, how-
ever, to demonstrate special features for each of these
varieties of MPGN. In MPGN with DIMD the C3
concentrations in the plasma are nearly always con-
stantly very low while the Clq, C4 and C3 PA con-
centrations may fluctuate but have normal mean
levels (Figs. 13 and 14). In contrast, in MPGN with
SED the levels of C3 are rarely constantly very low.
They are most often normal, and when low at onset
tend to become normal during the course of the
disease. In approximately one-half of the cases, the
Clq and C4 concentrations are low or fluctuant and
the mean levels are lower than normal. Low or fluctu-
ant levels of C3 PA may be observed as well. In
neither of the groups have we been able to establish a
correlation between variations in plasma complement
components concentrations and the clinical course.
Neither the degree of proteinuria nor the occurrence of
clinical remissions nor the use of immunosuppressants
have an effect on these levels [27].
Immunofluorescence microscopy reveals in all cases
of MPGN with DIMD the presence of intense granular
deposits in the mesangium and of weak "linear" de-
posits on the basement membranes fixing anti-/1C
serum. There is no deposition of immunoglobulins,
early components of complement or properdin. In con-
trast, in MPGN with SED two different patterns are
observed: in most cases coarsely granular subendo-
thelial deposits containing 1C-gIobulin, immunoglob-
ulins, Clq, C4 and sometimes properdin outline the
periphery of the tuft. In some rare cases these granular
subendothelial deposits contain only 1C-globulin and
properdin [27].
Therefore, MPGN with SED represents a hetero-
geneous group according to the results of immuno-
fluorescence microscopy and complement studies. In
some patients, the presence of immunoglobulins, Clq
and C4 associated with /1C in the glomeruli as well as
the finding of reduced plasma C4 concentrations sug-
gest the existence of an activation of the complement
sequence by the classical pathway. In this pathway, the
activation of complement appears to be induced by
immune complexes; however, recruitment of the alter-
nate pathway might occur. In others, the absence of
immunoglobulins and of early components of comple-
ment, as well as the presence of 1C globulin and of
properdin in the glomeruli, suggests activation of corn-
plement by the alternate pathway.
On the other hand, MPGN with DIMD represents a
homogeneous group in which the characteristic profile
of serum complement components (persistently low C3
associated with most often normal Clq, C4 and C3
PA) and the predominant presence of C3 in the glomer-
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uli suggest activation of complement through the
alternate pathway.
The role of C3 NeF in hypocomplementemic patients
is still debated [28]. C3 NeF was present in the serum of
two of our patients presenting with lipodystrophy
while it was not found in the third patient (Dr. K.
Peters). Another surprising fact is the absence of pro-
perdin in the glomeruli of our patients, thus suggesting
that properdin might not be involved in the activation
of complement.
Moreover, the pattern seen by immunofluorescence
(weak "linear" deposits of C3 on the basement mem-
brane and coarsely granular in the mesangium) indi-
cates that the characteristic dense material replacing the
lamina densa might not represent immune deposits. As
suggested by Mahieu [29], this anomaly could be due
to a modification of the biochemical composition of
the basement membrane. It remains to be determined
whether the lesion represents a primary disorder in the
basement membrane material with subsequent involve-
ment of the complement system, or a primary disorder
of the complement system resulting in a biochemical
transformation of the basement membrane.
Another feature of MPGN with DIMD is the con-
stant recurrence of the disease in transplanted kidneys
[30], while recurrence has been rarely reported in
MPGN with SED [31, 32]. Within a year or so after
transplantation, all our patients were found to have
dense deposits in their glomerular basement mem-
branes (in the absence of proliferation of mesangial
cells) as well as in Bowman's capsule and tubular base-
ment membranes. This factor adds to the specificity of
the lesion.
Although there are no significant clinical differences
between the two varieties of MPGN, the results of im-
munopathologic and complement studies seem to im-
ply different pathogenetic mechanisms. MPGN with
DIMD may therefore warrant separate classification.
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